Live AusBiotech News with Latest Updates

Live AusBiotech news and developments with the latest updates. Check out current AusBiotech news stories and find out what happened, what is going on with AusBiotech. Recent news updates about AusBiotech
2021 Federal Budget backs biotech
Prescient signs CAR-T agreement with Peter Mac Cancer Centre
Bionomics expands study of BNC210 to include social anxiety disorder
International IP protection at risk for COVID-19 vaccines
Emails re: AusBiotech conference lists
Nyrada announces to new cholesterol-lowering drug candidates
Last chance to register for AusMedtech 2021
Recce Pharmaceuticals’ R327 shows promise against pathogens
Australian drug discovery to be studied in US
Companies sought for AusBiotech’s new pitching series
Orthocell says study results open US market opportunity
Exopharm completes $12 million capital raise
Australian medtech consultancy merges with international leader
AusBiotech appoints new director, Dr James Campbell
Pharmaxis sells Bronchitol rights in Russia and completes placement
Amplia completes dosing in phase one study of AMP945
CSL’s Plasma Protein Purification Challenge opens
Australian-led discovery could speed up bone implant recovery
European approval for AnteoTech’s COVID-19 test
AusBiotech responds to university research commercialisation consultation
Approval to start trial of new Australian COVID-19 vaccine
Recce Pharmaceuticals: Patient response encouraging
Opportunity to join Team Australia at BIO
Noxopharm applies to patent Veyonda in septic shock treatment
Grant open for Boosting Female Founders Initiative – round 2
UK launch for Starpharma’s COVID-19 nasal spray
World-first trial for Australian company Pharmaxis
Investment support for early-stage translation
Pfizer hosts stakeholder roundtable on future of Australian life sciences
AusMedtech 2021: best value registration available for few more days
Nyrada raises $11 million in new placement
Novartis oncology leader joins board of local biotech
Modernising and future-proofing Gene Technology Scheme
NSW ensures access to GM crop innovation
Opthea launches late-stage study of eye therapy
New collaboration between Immutep and MSD
New plans for Australia’s biggest biotech industry gathering 16 March
Neuren completes drug substance manufacturing for NNZ-2591 trials
New plans for Australia’s biggest biotech industry gathering
Expert Leadership Forum announced to drive industry’s Biotech Blueprint strategy
Three women leading emerging Australian biotech
Noxopharm launches second part of NOXCOVID-1 clinical trial
NSW responds to industry opportunities
Kazia Therapeutics signs global agreement for lead candidate
Orthocell confirms Australian reimbursement for CelGro
AusMedtech 2021 programme launched
Botanix expands its management team
Cynata Therapeutics announces new study of cell therapy